Inhibition of the iNOS pathway in inflammatory macrophages by low-dose X-irradiation in vitro: Is there a time dependence?

Strahlentherapie und Onkologie

Volumn 179, Issue 3, 2003, Pages 158-166

  Hildebrandt, Guido ^a,b   Loppnow, Gabriela ^a   Jahns, Jutta ^a   Hindemith, Marion ^a   Anderegg, Ulf ^a   Saalbach, Anja ^a   Kamprad, Friedrich ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Hemoxygenase 1 (HO 1); Inducible nitric oxide synthase (iNOS); Inflammation; Low dose radiotherapy; Macrophages; Proteasome

Indexed keywords

GAMMA INTERFERON; HEME OXYGENASE 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; LOW ENERGY RADIATION; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; X IRRADIATION;

ANALYSIS OF VARIANCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CULTURE MEDIA; CYSTEINE ENDOPEPTIDASES; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION; HUMANS; LINEAR MODELS; MACROPHAGE ACTIVATION; MODELS, THEORETICAL; MULTIENZYME COMPLEXES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; RADIATION DOSAGE; RNA; RNA, MESSENGER; SPECTROPHOTOMETRY; TIME FACTORS;

EID: 0037336996     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1044-x     Document Type: Article

References (37)

1. Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 2001;15:831-45.
2. Albakri QA, Stuehr DJ. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J Biol Chem 1996;271:5414-21.
3. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 1998;10:263-8.
4. Amin AR, di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995;182:2097-102.
5. Brahn E, Banquerigo ML, Firestein GS, Boyle DL, Salzman AL, Szabo C. Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel anti-inflammatory agent with a combined mechanism of action. J Rheumatol 1998;25:1785-93.
6. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 1993;90:11419-23.
7. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21.
8. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA. Inhibition of inducible nitric oxide synthase by peroxysome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 1998;161:978-84.
9. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-12.
10. Elbirt KK, Bonkovsky HL. Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians 1999;111:438-47.
11. Evans CH, Stefanovic-Racic M. Nitric oxide in arthritis. Methods 1996;10:38-42.
12. 60-irradiation in the course of aseptic arthritis of the knee joint of rabbits. Strahlenther Onkol 1998;174:633-9.
13. Groß MW, Sattler A, Haake M, Schmitt J, Hildebrandt R, Müller HH, Engenhart-Cabilic R. The effectiveness of radiation treatment in comparison with extracorporeal shockwave therapy (ESWT) in supraspinatus tendon syndrome. Strahlenther Onkol 2002;178:314-20.
14. Hildebrandt G, Jahns J, Hindemith M, Spranger S, Sack U, Kinne RW, Madaj-Sterba P, Wolf U, Kamprad F. Effects of low dose radiation therapy on adjuvant induced arthritis in rats. Int J Radiat Biol 2000;76:1143-53.
15. Hildebrandt G, Radlingmayr A, Rosenthal S, Rothe R, Jahns J, Hindemith M, Kamprad F. Niedrig dosierte Radiotherapie moduliert die iNOS-Expression in der Adjuvans-Arthritis der Ratte. Exp Strahlenther Klin Strahlenbiol 2001;10:14-8.
16. Hildebrandt G, Seed MP, Freemantle CN, Alam CAS, Colville-Nash PR, Trott KR. Mechanisms of anti-inflammatory activity of low dose radiation therapy. Int J Radiat Biol 1998;74:367-78.
17. Hildebrandt G, Seed MP, Freemantle CN, Alam CAS, Colville-Nash PR, Trott KR. Effects of low dose ionizing radiation on murine chronic granulomatous tissue. Strahlenther Onkol 1998;174:580-8.
18. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 1998;48:249-57.
19. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
20. Masters BSS, McMillan K, Sheta EA, Nishimura JS, Roman LJ, Martasek P. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxytates L-arginine to produce NO as a cellular signal. FASEB J 1996;10:552-8.
21. Musial A, Eissa NT. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 2001;276:24268-73.
22. Pajonk F, McBride WH. Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. Radiother Oncol 2001;59:203-12.
23. Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999;26:2002-14.
24. Reinisch N, Mur E, Herold M, Dunzendorfer S, Kahler CM, Falkenbach A, Wiedermann CJ. Decrease of respiratory burst in neutrophils of patients with ankylosing spondylitis by combined radon-hyperthermia treatment. Clin Exp Rheumatol 1999;17:335-8.
25. Rödel F, Kamprad F, Sauer R, Hildebrandt G. Funktionelle und molekulare Aspekte der antiinflammatorischen Wirkung niedrig dosierter Radiotherapie. Strahlenther Onkol 2002;178:1-9.
26. 1-induced downregulation of leucocyte/endothelial cell adhesion. Int J Radiat Biol 2002;78:711-9.
27. Schaue D, Marples B, Trott KR. The effects of low dose X-irradiation on the oxidative burst in stimulated macrophages. Int J Radiat Biol 2002;78:567-76.
28. Schittkowski M, Schneider H, Gruschow K, Ziegler PG, Guthoff R, Fietkau R. 3 years experience with low dosage fractionated percutaneous teletherapy in subfoveal neovascularization. Clinical results. Strahlenther Onkol 2001;177:345-53.
29. Seegenschmiedt MH, Katalinic A, Makoski HB, Haase W, Gademann G, Hassenstein E. Radiotherapy of benign diseases: a pattern of care study in Germany. Strahlenther Onkol 1999;175:541-7.
30. St. Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatic arthritis patients. J Exp Med 1996;184:1173-8.
31. Tak PP, Firestein GS. NFκB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
32. Trott KR. Therapeutic effects of low radiation doses. Strahlenther Onkol 1994;170:1-12.
33. Trott KR, Kamprad F. Radiobiological mechanisms of antiinflammatory radiotherapy. Radiother Oncol 1999;51:197-203.
34. Vodovotz Y, Bogdan C. Control of nitric oxide synthase expression by transforming growth factor-β: implications for homeostasis. Prog Growth Factor Res 1994;5:341-51.
35. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J Immunol 1994;152:4110-8.
36. Willis D, Moore AR, Frederick R, Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 1996;2:87-90.
37. Zamora RY, Vodovotz Y, Billiar TR. Inducible nitric oxide synthase and inflammatory diseases. Mol Med 2000;6:347-73.